ClinicalTrials.gg

Drug

Geranylgeranylacetone clinical trials

Also written Teprenone.

studies test it
6
open now
2
in phase 3
0
first study started
2005

Keep track of what changes. Save the geranylgeranylacetone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Brand

Selbex
1

Other names

Teprenone
2

Studies by the year they started

6 studies that test it; most in 2026 (2)

Studies that test geranylgeranylacetone, by start year
YearStudies
20051
20071
20101
20231
20262

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 4
2
No phase
3

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 2 · Other 4

Eisai Co., Ltd. (2) · Amsterdam UMC, location VUmc (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · First Affiliated Hospital of Zhejiang University (1) · Sun Yat-sen University (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses geranylgeranylacetone is read from its arms, and is right about nine times in ten.

Testing it · 6

As the comparator · 1 — what is tested is compared with geranylgeranylacetone

Codes

What other systems call geranylgeranylacetone · ClinicalTrials.gg INT002940

  • MeSH (NLM) C031049geranylgeranylacetoneConfirmed ClinicalTrials.gov, NLM

Also registered as teprenone (UNII S8S8451A4O · RxNorm 1362746).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.